An important announcement from the Department of Health and Human Services
We wanted to share this important announcement from Health and Human Services: In an effort to get evidenced-based treatment to more Americans with opioid use disorder, the Department of Health and Human Services (HHS) is releasing new buprenorphine practice guidelines that among other things, remove a longtime requirement tied to training, which some practitioners have […]
ICYMI: SAMHSA’s New Series of Advisories on Substance Use Disorder Treatment
SAMHSA has published a series of Advisories based on existing Treatment Improvement Protocols (TIPs) and Technical Assistance Publications (TAPs). These Advisories summarize updated guidance and recommendations on topics in the substance use disorder (SUD) treatment field. View Advisories
Announcing President Biden’s New Team and Priorities at ONDCP
Dear Friends, I’m writing to introduce myself and to provide some updates for you on the Biden-Harris Administration’s efforts to quickly bring on committed and experienced leadership at ONDCP. On the first day of the Administration, I was sworn in as Deputy Director for National Drug Control Policy. I will serve as Acting Director until […]
FAQs About 42 CFR Part 2
Following a webinar hosted by American Academy of Addiction Psychiatry, American Psychiatric Association, and American Society for Addiction Medicine regarding 42 CFR Part 2, the Center of Excellence for Protected Health Information (CoE-PHI) prepared the following answers to frequently asked questions (FAQs) that were raised by participants. View FAQs
HHS Proposes to Eliminate MAT Waiver Requirement for Some Physicians
Eliminates X-Waiver Requirement for DEA-Registered Physicians Today, the U.S. Department of Health and Human Services is announcing it will publish Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder*, to expand access to medication-assisted treatment (MAT) by exempting physicians from certain certification requirements needed to prescribe buprenorphine for opioid use disorder (OUD) […]
Pediatricians Issue Guidance on Opioid Use During Pregnancy
American Academy of Pediatrics Calls for Systemic, Coordinated and Holistic Approach to Help Mothers, Infants Affected by Opioid Crisis Read Article
DEA Issues Interim Final Rule Clarifying MAT Dispensing
Implementation of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment Read the document
Center for Medicaid and Medicare Services (CMS) reaffirmed to states state Medicaid programs are required to provide coverage of MAT services and drugs
Read the article here.
Dr. McCance-Katz delivers video message to celebrate beginning of Recovery Month
In recognition of National Recovery Month, Assistant Secretary for Mental Health and Substance Use, Dr. Elinore McCance-Katz, honors the millions of Americans who have achieved recovery from mental and substance use disorders. Watch her video message celebrating the work done by the recovery community and the impressive strides in the fight against addiction.
Enhanced Provider Relief Fund Payment Portal
Providers eligible for additional allocations must provide HHS with information, and these providers must also agree to the program Terms and Conditions. This portal is currently open to Medicaid/CHIP Providers. Apply For Funding Medicaid/CHIP Provider Relief Fund Payment Forms and Guidance HHS expects to distribute $15 billion to eligible Medicaid and CHIP providers. The payment […]
